IO Biotech Investor Relations Material
Latest events
Status Update
IO Biotech
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from IO Biotech Inc
Access all reports
IO Biotech Inc. is a biotechnology company focused on developing immunotherapies for cancer. The company specializes in therapeutic cancer vaccines designed to stimulate the immune system to target and eliminate tumor cells. Its pipeline includes investigational treatments for various cancers, advancing through clinical trials and regulatory evaluations. The company is headquartered in Copenhagen, Denmark, and its shares are listed on the NASDAQ.
Key slides for IO Biotech Inc
Corporate Presentation
IO Biotech Inc
Corporate Presentation
IO Biotech Inc
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
IOBT
Country
🇺🇸 United States